NIH-funded research R21 grant

Creating stem cell lines from Xenopus frogs

Official title: Establishment of xenopus stem cell lines

Funded at University of Wisconsin Milwaukee · NIH-10892196 · Data updated 2026-11-12

This study is working on creating special stem cell lines from a frog species called Xenopus laevis to help scientists better understand human diseases and how our bodies develop, making research more reliable than using human or mouse cells.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin Milwaukee
NIH-funded
Lab location1 site (Milwaukee, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$192,500
NIH project number5R21OD033669-02
Project IDNIH-10892196 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals with conditions that can be modeled using Xenopus, such as congenital heart disorders or neurodevelopmental disorders.

Less likely to help

Patients with conditions that cannot be effectively modeled using Xenopus or those who do not have a direct link to the biological processes being studied may not receive benefit from this research.

What this research studies

This research focuses on developing stem cell lines from the Xenopus laevis species, which is a valuable model for studying various biological processes and diseases. By establishing these cell lines, researchers aim to overcome limitations in current in vitro models that often rely on human or mouse cells, which can introduce variability. The project will utilize advanced techniques to isolate and culture these cells, enabling better analysis of cellular processes and disease modeling. This work could significantly enhance our understanding of human diseases and developmental biology.

Why it matters

Potential benefit: If successful, this research could provide new tools for studying human diseases and developing therapies using a more relevant biological model.

How similar studies have gone: Previous research has shown success in using Xenopus as a model organism for studying various diseases, indicating that this approach has potential for meaningful advancements.

Where this research is happening

  • University of Wisconsin Milwaukee
    Milwaukee, United States
    Active

Researchers

  • Principal investigator: Gouignard, Nadege — University of Wisconsin Milwaukee
  • Study coordinator: Gouignard, Nadege

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.